Price to Sales ratio Analysis of CTi Biopharma Corp - Deep Dive


Latest FY PS
Period Ending - Dec-22

19.33


Very Poor PS
Period Ending - Dec-21
0

Very Poor PS
Growth
0 %
Trailing Twelve Months PS
Period Ending - Dec-22

14.29


Very Poor PS
PS Analysis of CTi Biopharma Corp
P/S Ratio of CTi Biopharma Corp with value of 14.29 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of CTIC has grown by 0 % Compared to previous Financial Year.
PS Ratio with value of 153969 was highest in Year Dec-20 in last Five Years.
PS Ratio with value of 0 was lowest in Year Dec-21 in last Five Years.
Latest PS Ratio with value of 19.33 is lower than Average PS of 30833.14 in last five years.
Other PS Related Info of CTIC that may interest you.
CTi Biopharma Corp Overview
CodePricePrevious PricePrice ChangeSector
CTIC9.099.09 0 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Poor Value Stock
FY - Historical Price to Sales of CTi Biopharma Corp
PeriodDec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16
PS19.330153969157.5419.3913.170.443
Change0 %97631.27 %712.59 %47.16 %2876.93 %-72.02 %
You are view first 7 Records. Log in to view all 27 in Premium view
FY Chart of Price to Sales of CTi Biopharma Corp


Note : All Data Generated at the End of Trading Hours (EOD Data)